Exchange: BATS·Updated 09:16 PM EST
ARKG logo

ARKG ARK Investment Management LLC - ARK Genomic Revolution ETF

$46.56
$1.98
(4.10%)
Today
Closed $46.27
$0.29
(0.63%)
Overnight
Vol4.39M
52W High$58.83
52W Low$24.60
37

Bearish Sentiment

How do you feel about ARKG?

RosannaInvests
Why are biotechs running? Look at the last six weeks. 🧐 $ARKG 🧬 → Sep: FDA clears $PRME to start its in-body prime editing trial for Alpha-1. $TWST hits 52-week highs on its Lilly AI deal. ARK adds gene editing. → Oct: $TEM clears antitrust for the Personalis deal. Merck KGaA buys Silence at a ~130% premium. Gilead pays $1.275B for a Phase 1 pill. → Last week: FDA draft guidance lets one application cover many patient-specific gene edits. $BEAM shows proof of concept for BEAM-301. Editors rip. Catalysts stacking on catalysts. The cost of failure is falling. The buyers are showing up. The re-rate already started. Not FA. DYOR.
4
CactusPicksEm
$ARKG 4.40 a share in short call premium received selling way OTM calls since June, not bad
1manfund
Genomics cycle post-COVID versus driven by AI drug discovery Prices have gone up but valuations are still a fraction of the 2021 ratings $ARKG
madnessofcrowds
$ARKG really nice bounce off the prior highs, volume coming in. let's see if rotation out of the mega caps continues.

Advertisement|Remove ads.